<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04000386</url>
  </required_header>
  <id_info>
    <org_study_id>zincoxide_PK</org_study_id>
    <nct_id>NCT04000386</nct_id>
  </id_info>
  <brief_title>A Study of Efficacy of Zinc Oxide Nanoparticles Coated Socks in Prevention of Unpleasant Foot Odor</brief_title>
  <official_title>A Study of Efficacy of Zinc Oxide Nanoparticles Coated Socks in Prevention of Unpleasant Foot Odor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to study the efficacy of zinc oxide nanoparticles coated socks in prevention&#xD;
      of unpleasant foot odor&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction Pitted keratolysis is a common skin disease, caused by various gram-positive&#xD;
      bacteria including Corynebacterium species, Kytococcus sedentarius, Dermatophilus congolensis&#xD;
      and Actinomyces species. These bacteria create small tunnels in the stratum corneum, causing&#xD;
      pitted lesions at plantar areas. This condition is frequent accompanied by feet malodor and&#xD;
      is commonly found in young male adults, especially in soldiers, miners and athletes. The&#xD;
      reported prevalence of pitted keratolysis among naval cadets in Thailand was 38.7%.&#xD;
      Predisposing factors related to pitted keratolysis are pedal hyperhidrosis and prolonged feet&#xD;
      occlusion. Although this condition is generally not painful, our previous study in 2018&#xD;
      revealed adversely affects patients' quality of life.&#xD;
&#xD;
      Regarding treatment modalities of pitted keratolysis, various medications and life-style&#xD;
      modification have been recommended. Previous studies revealed efficacy of topical choices,&#xD;
      including benzoyl peroxide gel, clindamycin-benzoyl peroxide gel, glycopyrrolate cream,&#xD;
      erythromycin gel, clindamycin solution, chlorhexidine scrub4 and mupirocin ointment. Oral&#xD;
      antibiotics and botulinum toxin injection were also beneficial in pitted keratolysis. As to&#xD;
      life-style modification, wearing cotton socks and opened footwear, and proper hygiene, have&#xD;
      also been suggested.&#xD;
&#xD;
      Previous studies demonstrated efficacy of zinc oxide in broad-spectrum antibacterial&#xD;
      properties. Thus, zinc oxide has been used in various medical and apparel industrial&#xD;
      products. Moreover, Commander Choopong Chailark invented socks coated with zinc oxide&#xD;
      nanoparticles and reported antibacterial property of those socks.&#xD;
&#xD;
      Objective The present study aimed to study the efficacy of zinc oxide nanoparticles coated&#xD;
      socks in prevention of unpleasant foot odor&#xD;
&#xD;
      Material and Methods First-year naval rating cadets, who had no pedal malodor were invited to&#xD;
      enroll in this study. Consent was informed and obtained from all participants. Participants&#xD;
      were assessed for behavioral risk factors and level of foot odor measured by a self-assessed&#xD;
      visual analogue scale (VAS), using questionnaires. Subjects were randomly assigned either&#xD;
      zinc oxide nanoparticles coated socks or ordinary socks.During the study, using of other&#xD;
      topical treatment such as topical antibiotics, antiperspirant or aluminum chloride was not&#xD;
      allowed. Participants were advised to wear those socks every day and regularly washed thier&#xD;
      socks. All were able to regularly participate in physical military training during the study.&#xD;
      Two weeks after the study clinical examinations by dermatologists and the cadets'&#xD;
      self-assessment questionnaires, including feet odor by using VAS, treatment satisfaction and&#xD;
      adverse effects, were used to evaluate the effectiveness. Pitted lesions improvement at&#xD;
      plantar areas, evaluated by dermatologists, was divided into no improvement, slight&#xD;
      improvement (decrease of pitted lesions at feet for 1 level) and much improvement (decrease&#xD;
      of pitted lesions at feet for at least 2 level). Data were analyzed using Predictive&#xD;
      Analytics SoftWare Statistics version 18 (SPSS, Inc., Chicago, Illinois, USA).&#xD;
&#xD;
      Duration of study: 4 months&#xD;
&#xD;
      Study design: Randomized control trial&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 26, 2019</start_date>
  <completion_date type="Actual">February 25, 2021</completion_date>
  <primary_completion_date type="Actual">February 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Single (Participant) Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Single blind controlled trial between participants, drug preparing team, doctors, investigators, and outcome assessors.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of zinc oxide nanoparticles coated socks in prevention of unpleasant foot odor</measure>
    <time_frame>2 weeks</time_frame>
    <description>Effectiveness was evaluated by the number of patients who had no or minimal foot odor after prevention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effectiveness of zinc oxide nanoparticles coated socks in prevention of fungal feet infection</measure>
    <time_frame>2 weeks</time_frame>
    <description>Effectiveness was evaluated by the number of patients who had no fungal feet infection after prevention</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">124</enrollment>
  <condition>Zinc Oxide</condition>
  <condition>Foot Dermatoses</condition>
  <arm_group>
    <arm_group_label>zinc oxide nanoparticles coated socks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>62 patients with zinc oxide nanoparticles coated socks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>62 patients with placebo socks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>zinc oxide nanoparticles coated socks</intervention_name>
    <description>zinc oxide nanoparticles coated socks were given to subjects for 2 weeks</description>
    <arm_group_label>zinc oxide nanoparticles coated socks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo socks</intervention_name>
    <description>placebo socks were given to subjects for 2 weeks</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  First-year naval rating cadets, who had no pedal malodor&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The cadets who previously received any topical treatment including topical antibiotic,&#xD;
             antiperspirant or aluminum chloride within 6 months prior to the study.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Dermatology Siriraj Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <results_reference>
    <citation>de Almeida HL Jr, Siqueira RN, Meireles Rda S, Rampon G, de Castro LA, Silva RM. Pitted keratolysis. An Bras Dermatol. 2016 Jan-Feb;91(1):106-8. doi: 10.1590/abd1806-4841.20164096.</citation>
    <PMID>26982791</PMID>
  </results_reference>
  <results_reference>
    <citation>Makhecha M, Dass S, Singh T, Gandhi R, Yadav T, Rathod D. Pitted keratolysis - a study of various clinical manifestations. Int J Dermatol. 2017 Nov;56(11):1154-1160. doi: 10.1111/ijd.13744. Epub 2017 Sep 18.</citation>
    <PMID>28924971</PMID>
  </results_reference>
  <results_reference>
    <citation>van der Snoek EM, Ekkelenkamp MB, Suykerbuyk JC. Pitted keratolysis; physicians' treatment and their perceptions in Dutch army personnel. J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1120-6. doi: 10.1111/j.1468-3083.2012.04674.x. Epub 2012 Aug 7.</citation>
    <PMID>22882561</PMID>
  </results_reference>
  <results_reference>
    <citation>Leeyaphan C, Bunyaratavej S, Taychakhoonavudh S, Kulthanachairojana N, Pattanaprichakul P, Chanyachailert P, Ongsri P, Arunkajohnsak S, Limphoka P, Kulthanan K. Cost-effectiveness analysis and safety of erythromycin 4% gel and 4% chlorhexidine scrub for pitted keratolysis treatment. J Dermatolog Treat. 2019 Sep;30(6):627-629. doi: 10.1080/09546634.2018.1543846. Epub 2018 Dec 11.</citation>
    <PMID>30415588</PMID>
  </results_reference>
  <results_reference>
    <citation>Vlahovic TC, Dunn SP, Kemp K. The use of a clindamycin 1%-benzoyl peroxide 5% topical gel in the treatment of pitted keratolysis: a novel therapy. Adv Skin Wound Care. 2009 Dec;22(12):564-6. doi: 10.1097/01.ASW.0000363468.18117.fe.</citation>
    <PMID>19935134</PMID>
  </results_reference>
  <results_reference>
    <citation>Bunyaratavej S, Leeyaphan C, Chanyachailert P, Pattanaprichakul P, Ongsri P, Kulthanan K. Clinical manifestations, risk factors and quality of life in patients with pitted keratolysis: a cross-sectional study in cadets. Br J Dermatol. 2018 Nov;179(5):1220-1221. doi: 10.1111/bjd.16923. Epub 2018 Sep 14.</citation>
    <PMID>29951993</PMID>
  </results_reference>
  <results_reference>
    <citation>Burkhart CG. Pitted keratolysis: a new form of treatment. Arch Dermatol. 1980 Oct;116(10):1104.</citation>
    <PMID>7425659</PMID>
  </results_reference>
  <results_reference>
    <citation>Balić A, Bukvić Mokos Z, Marinović B, Ledić Drvar D. Tatami Mats: A Source of Pitted Keratolysis in a Martial Arts Athlete? Acta Dermatovenerol Croat. 2018 Apr;26(1):68-70. Review.</citation>
    <PMID>29782305</PMID>
  </results_reference>
  <results_reference>
    <citation>Kontochristopoulos G, Sidiropoulou P, Tzanetakou V, Markantoni V, Platsidaki E, Agiasofitou E, Rigopoulos D, Gregoriou S. Managing pitted keratolysis: consider topical glycopyrrolate. Clin Exp Dermatol. 2019 Aug;44(6):713-714. doi: 10.1111/ced.13851. Epub 2018 Dec 4.</citation>
    <PMID>30515854</PMID>
  </results_reference>
  <results_reference>
    <citation>Pranteda G, Carlesimo M, Pranteda G, Abruzzese C, Grimaldi M, De Micco S, Muscianese M, Bottoni U. Pitted keratolysis, erythromycin, and hyperhidrosis. Dermatol Ther. 2014 Mar-Apr;27(2):101-4. doi: 10.1111/dth.12064. Epub 2013 May 24.</citation>
    <PMID>24703267</PMID>
  </results_reference>
  <results_reference>
    <citation>Greywal T, Cohen PR. Pitted keratolysis: successful management with mupirocin 2% ointment monotherapy. Dermatol Online J. 2015 Aug 15;21(8). pii: 13030/qt6155v9wk. Review.</citation>
    <PMID>26437161</PMID>
  </results_reference>
  <results_reference>
    <citation>Vazquez-Lopez F, Perez-Oliva N. Mupirocine ointment for symptomatic pitted keratolysis. Infection. 1996 Jan-Feb;24(1):55.</citation>
    <PMID>8852468</PMID>
  </results_reference>
  <results_reference>
    <citation>Tamura BM, Cucé LC, Souza RL, Levites J. Plantar hyperhidrosis and pitted keratolysis treated with botulinum toxin injection. Dermatol Surg. 2004 Dec;30(12 Pt 2):1510-4.</citation>
    <PMID>15606827</PMID>
  </results_reference>
  <results_reference>
    <citation>Fiedot-Toboła M, Ciesielska M, Maliszewska I, Rac-Rumijowska O, Suchorska-Woźniak P, Teterycz H, Bryjak M. Deposition of Zinc Oxide on Different Polymer Textiles and Their Antibacterial Properties. Materials (Basel). 2018 Apr 30;11(5). pii: E707. doi: 10.3390/ma11050707.</citation>
    <PMID>29710873</PMID>
  </results_reference>
  <results_reference>
    <citation>Raghunath A, Perumal E. Metal oxide nanoparticles as antimicrobial agents: a promise for the future. Int J Antimicrob Agents. 2017 Feb;49(2):137-152. doi: 10.1016/j.ijantimicag.2016.11.011. Epub 2017 Jan 3. Review.</citation>
    <PMID>28089172</PMID>
  </results_reference>
  <results_reference>
    <citation>Dizaj SM, Lotfipour F, Barzegar-Jalali M, Zarrintan MH, Adibkia K. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:278-84. doi: 10.1016/j.msec.2014.08.031. Epub 2014 Aug 16. Review.</citation>
    <PMID>25280707</PMID>
  </results_reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>June 26, 2019</study_first_submitted>
  <study_first_submitted_qc>June 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2019</study_first_posted>
  <last_update_submitted>February 25, 2021</last_update_submitted>
  <last_update_submitted_qc>February 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pitted keratolysis</keyword>
  <keyword>zinc oxide</keyword>
  <keyword>Foot Odor</keyword>
  <keyword>preventsion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
    <mesh_term>Foot Dermatoses</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zinc Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

